- Home
- SGBX vs SLRX Comparison
SGBX vs SLRX Comparison
Compare SGBX & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- SLRX
- Stock Information
- Founded
- SGBX 2007
- SLRX N/A
- Country
- SGBX United States
- SLRX United States
- Employees
- SGBX N/A
- SLRX N/A
- Industry
- SGBX RETAIL: Building Materials
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- SLRX Health Care
- Exchange
- SGBX Nasdaq
- SLRX Nasdaq
- Market Cap
- SGBX 2.0M
- SLRX 2.1M
- IPO Year
- SGBX 2017
- SLRX N/A
- Fundamental
- Price
- SGBX $0.58
- SLRX $1.70
- Analyst Decision
- SGBX
- SLRX
- Analyst Count
- SGBX 0
- SLRX 0
- Target Price
- SGBX N/A
- SLRX N/A
- AVG Volume (30 Days)
- SGBX 915.3K
- SLRX 98.0K
- Earning Date
- SGBX 11-27-2024
- SLRX 11-14-2024
- Dividend Yield
- SGBX N/A
- SLRX N/A
- EPS Growth
- SGBX N/A
- SLRX N/A
- EPS
- SGBX N/A
- SLRX N/A
- Revenue
- SGBX $5,889,321.00
- SLRX N/A
- Revenue This Year
- SGBX $273.79
- SLRX N/A
- Revenue Next Year
- SGBX $39.31
- SLRX N/A
- P/E Ratio
- SGBX N/A
- SLRX N/A
- Revenue Growth
- SGBX N/A
- SLRX N/A
- 52 Week Low
- SGBX $0.38
- SLRX $1.22
- 52 Week High
- SGBX $10.40
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- SGBX 56.23
- SLRX 56.15
- Support Level
- SGBX $0.45
- SLRX $1.52
- Resistance Level
- SGBX $0.53
- SLRX $2.06
- Average True Range (ATR)
- SGBX 0.06
- SLRX 0.18
- MACD
- SGBX 0.03
- SLRX 0.03
- Stochastic Oscillator
- SGBX 61.32
- SLRX 57.14
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.